SHANGHAI FOSUN PHARMACEUTICAL GROUP revenue breakdown overview

SHANGHAI FOSUN PHARMACEUTICAL GROUP revenue for the last year amounted to 40.91 B CNY, the most of which — 28.92 B CNY — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 30.22 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought SHANGHAI FOSUN PHARMACEUTICAL GROUP 29.77 B CNY, and the year before that — 31.03 B CNY.